308 related articles for article (PubMed ID: 29535519)
1. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit
Naeem M; Bae J; Oshi MA; Kim MS; Moon HR; Lee BL; Im E; Jung Y; Yoo JW
Int J Nanomedicine; 2018; 13():1225-1240. PubMed ID: 29535519
[TBL] [Abstract][Full Text] [Related]
2. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW
Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440
[TBL] [Abstract][Full Text] [Related]
3. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V
Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.
Xiao B; Si X; Zhang M; Merlin D
Colloids Surf B Biointerfaces; 2015 Nov; 135():379-385. PubMed ID: 26275840
[TBL] [Abstract][Full Text] [Related]
5. New approach to treating spinal cord injury using PEG-TAT-modified, cyclosporine-A-loaded PLGA/polymeric liposomes.
Gao SJ; Liu Y; Wang HJ; Ban DX; Cheng SZ; Ning GZ; Wang LL; Chang J; Feng SQ
J Drug Target; 2017 Jan; 25(1):75-82. PubMed ID: 27250819
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model.
Melero A; Draheim C; Hansen S; Giner E; Carreras JJ; Talens-Visconti R; Garrigues TM; Peris JE; Recio MC; Giner R; Lehr CM
Eur J Pharm Biopharm; 2017 Oct; 119():361-371. PubMed ID: 28709903
[TBL] [Abstract][Full Text] [Related]
7. Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa--Pharmaceutical Characterization and Fluorescence Imaging.
Ali H; Weigmann B; Collnot EM; Khan SA; Windbergs M; Lehr CM
Pharm Res; 2016 May; 33(5):1085-92. PubMed ID: 26718953
[TBL] [Abstract][Full Text] [Related]
8. Drug delivery to inflamed colon by nanoparticles: comparison of different strategies.
Coco R; Plapied L; Pourcelle V; Jérôme C; Brayden DJ; Schneider YJ; Préat V
Int J Pharm; 2013 Jan; 440(1):3-12. PubMed ID: 22820482
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel disease.
Guada M; Beloqui A; Alhouayek M; Muccioli GG; Dios-Viéitez Mdel C; Préat V; Blanco-Prieto MJ
Int J Pharm; 2016 Apr; 503(1-2):196-8. PubMed ID: 26972380
[TBL] [Abstract][Full Text] [Related]
10. Enzyme/pH dual sensitive polymeric nanoparticles for targeted drug delivery to the inflamed colon.
Naeem M; Kim W; Cao J; Jung Y; Yoo JW
Colloids Surf B Biointerfaces; 2014 Nov; 123():271-8. PubMed ID: 25266978
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of Cyclosporine A loaded nanoparticles for ocular drug delivery: Cellular toxicity, uptake, and kinetic studies.
Aksungur P; Demirbilek M; Denkbaş EB; Vandervoort J; Ludwig A; Unlü N
J Control Release; 2011 May; 151(3):286-94. PubMed ID: 21241752
[TBL] [Abstract][Full Text] [Related]
12. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610
[TBL] [Abstract][Full Text] [Related]
13. Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting.
Pandey S; Vijayendra Swamy SM; Ubaid Ulla UM; Gupta A; Patel H; Yadav JS
Curr Drug Deliv; 2017 Sep; 14(6):887-899. PubMed ID: 27538461
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-loaded poly (lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications.
Chai F; Sun L; He X; Li J; Liu Y; Xiong F; Ge L; Webster TJ; Zheng C
Int J Nanomedicine; 2017; 12():1791-1802. PubMed ID: 28424550
[TBL] [Abstract][Full Text] [Related]
15. Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases.
Ali H; Weigmann B; Neurath MF; Collnot EM; Windbergs M; Lehr CM
J Control Release; 2014 Jun; 183():167-77. PubMed ID: 24685705
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
17. Spermidine-mediated poly(lactic-
Tang J; Li J; Li G; Zhang H; Wang L; Li D; Ding J
Int J Nanomedicine; 2017; 12():6687-6704. PubMed ID: 28932114
[TBL] [Abstract][Full Text] [Related]
18. In vitro degradation of poly (D, L-lactide-co-glycolide) nanoparticles loaded with linamarin.
Hussein AS; Abdullah N; Ahmadun FR
IET Nanobiotechnol; 2013 Jun; 7(2):33-41. PubMed ID: 24046903
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles made of multi-block copolymer of lactic acid and ethylene glycol containing periodic side-chain carboxyl groups for oral delivery of cyclosporine A.
Ankola DD; Battisti A; Solaro R; Kumar MN
J R Soc Interface; 2010 Aug; 7 Suppl 4(Suppl 4):S475-81. PubMed ID: 20504806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]